Stock PSG PHARMASGP HOLDING SE
Add to a list
To use this feature you must be a member
Log inSign up

All News PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Market Closed - Xetra
Other stock markets
 09:06:12 03/07/2024 pm IST 		5-day change 1st Jan Change
22.2 EUR 0.00% Intraday chart for PharmaSGP Holding SE -5.13% -1.33%
28/05 PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/04 PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PharmaSGP : Information according to Table 8 of the Implementing Regulation (EU) 2018/1212 (German Language)
PU
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
EQ
PharmaSGP Holding SE strengthens the Management Board to further accelerate growth
EQ
PharmaSGP : Interim Statement Q1 2024
PU
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
PharmaSGP : Sample Form for Revocation of Power of Attorney
PU
PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024
EQ
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
EQ
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023
CI
PharmaSGP Holding SE Announces Changes to Dividend Policy
CI
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSG Stock
  4. News PharmaSGP Holding SE